Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

Germany flag Germany · Delayed Price · Currency is EUR
2.040
-0.020 (-0.97%)
Last updated: Dec 4, 2025, 8:00 AM CET
-3.77%
Market Cap 4.89B
Revenue (ttm) 9.28B
Net Income (ttm) 357.55M
Shares Out n/a
EPS (ttm) 0.22
PE Ratio 13.69
Forward PE 14.56
Dividend 0.10 (4.68%)
Ex-Dividend Date Aug 29, 2025
Volume 400
Average Volume 93
Open 2.040
Previous Close 2.060
Day's Range 2.040 - 2.040
52-Week Range 1.840 - 2.300
Beta n/a
RSI 43.72
Earnings Date Mar 16, 2026

About FRA:GU5

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1997
Employees 27,425
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GU5
Full Company Profile

Financial Performance

In 2024, FRA:GU5's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.